Advertisement

Topics

Alnylam touts hemophilia drug's edge over Roche rival

10:54 EST 30 Nov 2016 | BioPharmaDive

With revusiran nixed, Alnylam hopes to launch Phase 3 studies of fitusiran early next year and catch up to Roche's experimental hemophilia drug

Original Article: Alnylam touts hemophilia drug's edge over Roche rival

NEXT ARTICLE

More From BioPortfolio on "Alnylam touts hemophilia drug's edge over Roche rival"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...